![BeardBros_BlogImages [Recovered]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjU2MCAyOTIiIHdpZHRoPSIyNTYwIiBoZWlnaHQ9IjI5MiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48L3N2Zz4=)
Key Takeaways
- Glass House Brands hired Matt Murphy, a former DEA official, to navigate compliance for interstate cannabis commerce and potential exports under Schedule III.
- This follows a pattern where the company hires former federal executives after significant regulatory events, signaling a proactive compliance strategy.
- Reclassification to Schedule III does not legalize interstate commerce but could relieve some tax burdens for cannabis companies.
- Glass House aims to sell California cannabis in the most lucrative markets, preparing for future federal legitimacy.
- The hiring of former federal officials raises questions about the industry’s direction and the impact on small operators versus larger companies.
Glass House Brands recently announced in a press release the retention of Matt Murphy, a former Drug Enforcement Administration official, to advise on DEA compliance related to interstate commerce and the export of medical cannabis under Schedule III of the Controlled Substances Act. Murphy spent 26 years with the DEA, serving as Chief of Pharmaceutical Investigations and retiring as Assistant Special Agent in Charge of its New England Field Division.
This is the second time in roughly a year that the California-based cannabis company has brought in a former federal agency executive following a major government action. The first came after a significant ICE raid in July 2025. The second comes on the heels of a federal reclassification that could reshape the entire cannabis market. Whether you read that as sharp business strategy or as something more calculated depends largely on where you sit in the industry.
What Is Glass House Brands’ Strategy With Former Government Officials?
The pattern is worth noting. On July 10th, 2025, federal officers led by U.S. Immigration and Customs Enforcement raided two of Glass House’s California farms. Approximately 360 individuals were detained or arrested for immigration violations, according to government and media reports. One third-party contractor employee, Jaime Alanis Garcia, died from injuries sustained during the raid.
Shortly after, Glass House announced in a press release it retained Guidepost Services, a compliance consulting firm led by Julie Myers Wood, the former Director of ICE and former Assistant Secretary of Homeland Security. Wood and her team were brought in to help implement best practices for employment eligibility verification.
Then, in April 2026, the acting U.S. Attorney General reclassified state-regulated medical cannabis to Schedule III under the Controlled Substances Act. About three months later, Glass House announces the recent the Murphy hire.
Two federal regulatory pressure points. Two former federal agency executives brought in shortly after each one. The timing is worth noting.
Who Is Glass House Brands New Hire?
According to Glass House Brands recent press release, Murphy is the founder and president of Pharma Compliance Group, an advisory firm that helps pharmaceutical manufacturers, distributors, and pharmacies comply with DEA regulations and the Controlled Substances Act. Before that, he spent over two decades as a DEA special agent.
His cannabis-specific experience comes from Khiron Life Sciences, a vertically integrated cannabis operator based in Colombia. From 2017 to 2021, Murphy served as Khiron’s Chief Compliance Officer, where he developed the company’s seed-to-sale tracking and compliance program. That work made Khiron the first Colombian medical cannabis producer to implement DEA-comparable controlled substance compliance protocols, enabling exports to Germany and the United Kingdom.
Glass House CEO Kyle Kazan put it plainly in the company’s press release: “Having lived it for more than two decades, Matt knows the inner workings of the DEA and controlled substance and pharmaceutical grade compliance.”
The hire is framed around preparation. Interstate cannabis commerce and exports remain prohibited under current federal law. Reclassification to Schedule III does not automatically open state lines or borders to cannabis products. But Glass House is clearly positioning itself ahead of frameworks that may one day permit such activity.
Does Schedule III Actually Allow Cannabis Interstate Commerce?
This is where things get more nuanced, and it is worth being precise about it. Reclassification to Schedule III changes how cannabis is regulated under the Controlled Substances Act, but it does not create a legal pathway for cannabis grown in California to be shipped to New York or exported to Europe.
For interstate commerce to become legal, Congress or federal regulatory agencies would need to establish specific frameworks governing how state-licensed cannabis products can cross state or national borders. That process has not begun in any formal capacity.
What Schedule III reclassification of state-level medical cannabis does do is relieve cannabis companies from Section 280E of the tax code, which previously barred them from deducting ordinary business expenses. It also changes how cannabis is classified medically and could open the door to more pharmaceutical-style oversight by the DEA.
Murphy’s role, as described by Glass House, is to help the company develop compliance systems that could eventually meet Schedule III federal requirements and the standards of markets outside California.
How Could the Cannabis Industry View This Kind of Hire?
There are two reads on this, and both are worth looking at.
From a corporate governance and investor relations standpoint, some you could argue they see hiring former federal agency executives as a smart compliance move, especially when a company has faced government scrutiny. It tells regulators, investors, and the public that the company is taking compliance seriously. For a publicly traded cannabis company currently navigating an unstable federal legal environment, some could argue that has value.
From the legacy cannabis community’s perspective, the view looks different. Licensing costs, compliance burdens, and tax structures have systematically shut small operators and legacy market participants out of the legal cannabis industry. When a well-capitalized company hires the former heads of the very agencies that enforce those burdens, it raises a legitimate question: who are we actually building this industry for?
Glass House is not doing anything unlawful by hiring former government officials. The revolving door between government agencies and private industry is well-documented across sectors, from defense contracting to finance to pharmaceuticals. But cannabis has a specific history that makes this dynamic feel sharper to those who have watched enforcement actions devastate small and legacy operators while better-resourced companies absorb the same pressures and move on.
What Is Glass House Brands Trying to Accomplish with This Approach?
According to Kazan’s public statements, the goal is straightforward: sell California cannabis in whatever markets offer the highest price. Glass House operates large-scale cultivation facilities in California and owns brands including Glass House Farms, PLUS Products, Allswell, and Mama Sue Wellness. The company’s scale and low-cost production model make it a strong candidate to benefit from interstate or international market access if that access ever becomes legal.
It is also worth noting that Glass House appears to be the only cannabis company publicly announcing these kinds of hires in direct response to regulatory events. Others may be doing similar things quietly. Glass House is making it a press release.
What Does This Mean for the Cannabis Industry?
Glass House Brands’ pattern of hiring former government agency executives raises a bigger question for the industry than it does for the company itself. As cannabis moves closer to some form of federal legitimacy, the companies that know how to operate within federal regulatory systems will have a structural advantage over those that do not.
The companies now hiring ex-DEA and ex-ICE officials are, by and large, the same ones that never had to worry about raids, asset forfeiture, or criminal records in the first place. Now they’re paying top dollar to bring enforcement insiders in-house, not because they care about justice or equity, but because it gives them a leg up as the rules get rewritten.
Meanwhile, the small operators and legacy market participants who actually built this industry, often at great personal risk, are getting squeezed out by the very regulatory complexity these new hires are being brought in to navigate.
None of that makes Glass House’s compliance strategy wrong. It does make it worth watching carefully, and worth noting out loud.
Frequently Asked Questions
Glass House Brands has hired a former DEA special agent to help navigate federal cannabis regulations, particularly around interstate commerce and potential medical cannabis exports under Schedule III. The move signals the company’s preparation for possible out-of-state distribution if federal law allows it.
Reclassifying cannabis to Schedule III does not automatically legalize interstate cannabis commerce. For that to happen, Congress or federal regulatory agencies would need to create specific legal frameworks. While the U.S. Attorney General reclassified state-regulated medical cannabis to Schedule III in April 2026, the question of interstate commerce remains unanswered.
On July 10, 2025, ICE raided two Glass House farms in California, detaining around 360 people, including nine Glass House employees, over suspected immigration violations. One contractor employee died from injuries sustained during the raid. In response, Glass House hired Guidepost Services, led by former ICE Director Julie Myers Wood, to improve its employment eligibility compliance.
Glass House Brands stands out as one of the few major cannabis companies publicly hiring former federal agency executives in response to regulatory changes, framing these appointments as part of its federal compliance strategy.
